StonvexLoading…
StonvexStonvexStonvexCore line items from JANX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.00M | $10.59M | $8.08M | $8.61M |
Operating Income | $-157.67M | $-98.85M | $-72.98M | $-67.09M |
Net Income | $-113.63M | $-68.99M | $-58.29M | $-63.06M |
EPS (Diluted) | $-1.83 | $-1.28 | $-1.32 | $-1.52 |
Total Assets | $1.00B | $1.06B | $380.41M | $364.01M |
Total Liabilities | $44.74M | $38.73M | $36.06M | $43.27M |
Cash & Equivalents | $52.33M | $430.61M | $19.20M | $51.43M |
Free Cash Flow OCF − CapEx | $-83.28M | $-44.17M | $-52.42M | $-49.37M |
Shares Outstanding | 60.38M | 59.06M | 46.25M | 41.62M |